China Pharma Inc.
CPHI | AMEX
$0.69
-$0.02 (-2.82%)
At close: Sep 21, 2026, 3:59 PM ET
$0.72
+$0.03 (+4.30%)
Pre-market:
Sep 22, 2026, 8:57 AM ET
Market Data
Market Cap $27.62M
Enterprise Value $-156.49B
Beta 1.05
Average Volume 4.44M
Shares Outstanding (Diluted) 40.52M
Shares Change YoY 1142.24%
Institutional Ownership 0.60%
Exchange AMEX
ISIN US16941T4013
Price Performance
Price Change 1M -31.0%
Price Change 3M -0.7%
Price Change 6M 7.8%
Price Change YTD -43.0%
Price Change 1Y -65.0%
Price Change 3Y -90.1%
Price Change 5Y -99.8%
1M CAGR (ann.) -39.7%
1Y CAGR (ann.) -65.4%
5Y CAGR (ann.) -71.0%
All-Time CAGR -29.4%
Valuation
PE Ratio -0.00
Forward PE N/A
PEG Ratio 0.03
Forward PEG 0.03
PS Ratio 0.00
Forward PS N/A
PB Ratio 0.00
P/FCF Ratio -0.00
P/Adj. FCF Ratio -0.00
P/OCF Ratio -23.00
EV/Sales -0.17
EV/EBIT 53,140.68
EV/EBITDA 0.11
EV/FCF 1.78
Earnings Yield -5215095.7%
FCF Yield -313617.5%
Adj. FCF Yield -313617.5%
Financial Health
Net Cash $156.51B
Total Debt $148.36B
Cash & Short-Term Investments $304.87B
Total Assets $44.71T
Current Ratio 0.26
Quick Ratio 0.08
Debt / Equity Ratio 0.10
Debt / EBITDA -0.10
Debt / FCF -1.68
OCF / Debt -0.59
Interest Coverage -44.20
Altman Z-Score -1.54
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin -9.3%
Operating Profit Margin -151.0%
EBITDA Margin -36.8%
Net Profit Margin -114.3%
FCF Margin -9.3%
Adj. FCF Margin -9.3%
SBC / Revenue 0.0%
SBC Impact (per share) N/A
Returns
Return on Assets -10.0%
Return on Equity -17.1%
Return on Invested Capital -10.8%
Return on Capital Employed -11.8%
Return on Tangible Assets -70.2%
Historical Growth (CAGR)
Revenue CAGR 3Y 4823.7%
Revenue CAGR 5Y 887.4%
Revenue CAGR 10Y 199.8%
EPS CAGR 3Y -150.0%
EPS CAGR 5Y -100.0%
EPS CAGR 10Y -54.5%
FCF CAGR 3Y -150.0%
FCF CAGR 5Y -100.0%
FCF CAGR 10Y -54.5%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Aug 13, 2026
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Cash Flow
Operating Cash Flow $-88.12B
Free Cash Flow $-88.12B
Adj. Free Cash Flow $-88.12B
FCF Per Share -$0.05
OCF Per Share -$0.03
OCF/S Ratio -3.6%
Income Statement
Revenue $948.34B
Gross Profit $83.57B
Operating Income $-1.43T
EBITDA $-1.43T
Net Income $-1.46T
EPS (Diluted) -$35,984
Revenue / Employee $4.41B
Profit / Employee $-6.78B
Employees 215
Add to Watchlist
Select watchlists to add or remove CPHI